Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ
· Real-Time Price · USD
1.81
0.04 (2.26%)
At close: Aug 18, 2025, 1:46 PM
2.26% (1D)
| Bid | 1.8 |
| Market Cap | 8.29M |
| Revenue (ttm) | 893.99K |
| Net Income (ttm) | -21.65M |
| EPS (ttm) | -22.36 |
| PE Ratio (ttm) | -0.08 |
| Forward PE | -0.76 |
| Analyst | Hold |
| Ask | 1.89 |
| Volume | 93,201 |
| Avg. Volume (20D) | 157,983 |
| Open | 1.77 |
| Previous Close | 1.77 |
| Day's Range | 1.77 - 1.88 |
| 52-Week Range | 0.18 - 8.20 |
| Beta | 0.25 |
About MYNZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MYNZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MYNZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Mainz Biomed B.V. is scheduled to release its earnings on
Aug 26, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
+17.01%
Mainz Biomed shares are trading higher after the c...
Unlock content with
Pro Subscription
3 months ago
+4.82%
Mainz Biomed shares are trading higher after the company announced its Q1 corporate update and path to FDA premarket approval.
